Inflammatory cancer-associated fibroblasts (iCAFs) induced by FGF19 can secrete immunosuppressive factors such as interleukin-10 (IL-10) and transforming growth factor-β (TGF-β), which dampen anti-tumor immune responses. Here, IL10 is linked to neoplasm.